Aprepitant 125 mg/1 (Aprepitant CAPSULE) 125 mg/1

Aprepitant 125 mg capsules are used to prevent nausea and vomiting caused by chemotherapy. This antiemetic medication is part of a broader treatment plan for managing side effects of cancer therapy.

Strength

125 mg/1

Pack Size

1 BLISTER PACK in 1 CARTON (0781-2323-68) / 6 CAPSULE in 1 BLISTER PACK (0781-2323-06)

Manufacturer / TM Owner

Sandoz Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Aprepitant 125 mg capsules are primarily used to prevent nausea and vomiting in patients undergoing chemotherapy. This medication is often included in combination therapy to enhance its effectiveness. Patients may wonder, 'What is Aprepitant used for?' It is designed to manage symptoms associated with cancer treatment, providing relief from nausea and vomiting.

Side Effects

Aprepitant 125 mg capsules are known to help reduce the frequency and severity of nausea and vomiting. Some users may experience common effects such as fatigue, headache, or constipation. These effects can vary from person to person.

Precautions & Warnings

Aprepitant 125 mg capsules should be handled with care, following the prescribed guidelines. It is important to inform healthcare providers about any existing medical conditions or allergies. Proper storage and administration are crucial for optimal results.

Avoid Interactions

Aprepitant 125 mg capsules may interact with other medications, including those metabolized by the liver. It is advisable to consult a healthcare provider before combining Aprepitant with other treatments. Alcohol and certain foods may also affect its efficacy.

Frequently Asked Questions

Aprepitant is used to prevent nausea and vomiting caused by chemotherapy.

Aprepitant 125 mg capsules should be stored at room temperature, away from moisture and heat.

Aprepitant may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Common effects of Aprepitant may include fatigue, headache, or constipation.

Aprepitant should be used with caution in individuals with certain medical conditions or allergies.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.